On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.
On May 1, the U.S. Food and Drug Administration (FDA) approved Elelyso (taliglucerase alfa) for the treatment of Gaucher disease. Read more.